{
    "title": "BioNTech eyes up to 17 bln euros in vaccine revenue in 2022",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10390883/BioNTech-eyes-17-bln-euros-vaccine-revenue-2022.html",
    "date": "2022-01-11",
    "keywords": [
        "year",
        "vaccine",
        "phase",
        "biontech",
        "burger",
        "revenue",
        "development",
        "presentation",
        "product",
        "market",
        "oncology",
        "covid19",
        "pfizer",
        "cancer",
        "jp",
        "healthcare",
        "conference",
        "biotech",
        "firm",
        "tuesday",
        "guidance",
        "windfall",
        "comirnaty",
        "companys",
        "inception",
        "chance",
        "vision",
        "reinvestment",
        "company",
        "approval",
        "clearance",
        "testing",
        "tuberculosis",
        "sign",
        "growth",
        "headcount",
        "research",
        "staff",
        "sitholematarise"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}